Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Afcom Holdings Q3 FY26 earnings call: Revenue & Margins | Arthneeti
Q3 FY26
No explicit year-on-year growth or % change figures are stated in the slides . Key concall takeaways from Afcom Holdings Ltd's Q3 FY26 earnings call — and how…
25 Sept 2026
Afcom Holdings Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
EBITDA:** ₹78.34 crore, with a year-on-year (YoY) growth of 40.7%. Key concall takeaways from Afcom Holdings Ltd's Q1 FY26 earnings call — and how it ranks…
25 Sept 2026
SMS Pharmaceuticals Q1 FY27: Revenue ₹207 Cr, PAT ₹20 Cr | Arthneeti
Q1 FY27
Q1FY27 revenue from operations: ₹207 crore, up 6% YoY (Page 6, 5) . Key concall takeaways from SMS Pharmaceuticals Ltd's Q1 FY27 earnings call — and how it…
25 Sept 2026
SG Finserve Q1 FY25 earnings call: Revenue & Margins | Arthneeti
Q1 FY25
Interest Income for Q1 FY25: INR 42.83 crore, up 26% YoY from INR 34.07 crore in Q1 FY24. Key concall takeaways from SG Finserve Ltd's Q1 FY25 earnings call…
25 Sept 2026
SMS Pharmaceuticals Q3 FY25: Revenue ₹173.35 Cr, PAT ₹18.24 Cr | Arthneeti
Q3 FY25
Q3FY25 revenue from operations: ₹173.35 crore, up 7% YoY from ₹161.48 crore in Q3FY24 (Page 18, 5). Key concall takeaways from SMS Pharmaceuticals Ltd's Q3…
25 Sept 2026
SMS Pharmaceuticals Q1 FY26: Revenue ₹196.05 Cr, PAT ₹20.50 Cr | Arthneeti
Q1 FY26
Q1FY26 revenue from operations: ₹196.05 crore . Key concall takeaways from SMS Pharmaceuticals Ltd's Q1 FY26 earnings call — and how it ranks against sector…
25 Sept 2026
Tribhovandas Bhimji Zaveri Q2 FY26 earnings call: Revenue & Margins | Arthneeti
Q2 FY26
Q2 FY26 Revenue from operations: ₹6,878.28 million, up 21.30% YoY (from ₹5,670.47 million in Q2 FY25). Key concall takeaways from Tribhovandas Bhimji Zaveri…
25 Sept 2026
Tribhovandas Bhimji Zaveri Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Q4 FY25 revenue from operations: ₹5,293.43 million, a 4.51% increase YoY (Q4 FY24: ₹5,065.17 million) (Page 9, Page 8). Key concall takeaways from Tribhovandas…
25 Sept 2026
TARC Q1 FY27: Revenue ₹218.7 Cr, PAT ₹22.65 Cr | Arthneeti
Q1 FY27
Q1 FY2027 Revenue: ₹218.7 crore (up from ₹75.89 crore in Q1 FY2026), showing strong year-on-year growth. Key concall takeaways from TARC Ltd's Q1 FY27 earnings…
25 Sept 2026
Tribhovandas Bhimji Zaveri Q2 FY25 earnings call: Revenue & Margins | Arthneeti
Q2 FY25
Q2 FY25 revenue from operations: ₹5,670.47 million, a 17.99% YoY increase (Page 9, 8). Key concall takeaways from Tribhovandas Bhimji Zaveri Ltd's Q2 FY25…
25 Sept 2026
Tribhovandas Bhimji Zaveri Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
Q4 FY26 revenue from operations: ₹8,296.95 million, up 56.74% YoY (Page 9, 8) . Key concall takeaways from Tribhovandas Bhimji Zaveri Ltd's Q4 FY26 earnings…
25 Sept 2026
TARC Q4 FY26: Revenue ₹300.02 Cr, PAT ₹1.61 Cr | Arthneeti
Q4 FY26
Q4 FY2026 Revenue:** ₹300.02 crore, sharply up from ₹13.89 crore in Q4 FY2025 (over 20x YoY growth). Key concall takeaways from TARC Ltd's Q4 FY26 earnings…
25 Sept 2026
TARC Q3 FY26: Revenue ₹1,000 Cr, EBITDA margin 33.77% | Arthneeti
Q3 FY26
Revenue for Q3 FY26: ₹38.38 lakhs vs ₹9.35 lakhs in Q3 FY25 (approx. Key concall takeaways from TARC Ltd's Q3 FY26 earnings call — and how it ranks against…
25 Sept 2026
TARC Q4 FY25: Revenue ₹3,722 Cr, PAT ₹3,722 Cr | Arthneeti
Q4 FY25
Sales in FY25 were ₹3,722 crore, up from ₹520 crore in FY23, representing over 7x growth in 2 years. Key concall takeaways from TARC Ltd's Q4 FY25 earnings…
25 Sept 2026
TARC Q2 FY26: Revenue ₹565 Cr, EBITDA margin 24.66% | Arthneeti
Q2 FY26
Q2 FY26 Revenue:** ₹687.06 lakhs, up 59.31% from ₹431.28 lakhs in Q2 FY25 . Key concall takeaways from TARC Ltd's Q2 FY26 earnings call — and how it ranks…
25 Sept 2026
Unichem Laboratories Q4 FY17 earnings call: Revenue & Margins | Arthneeti
Q4 FY17
Quarter ended March 31, 2017 revenue from operations: INR 18,735 lakhs, up 7% YoY (from INR 17,447 lakhs in Q4 FY16) (Page 38). Key concall takeaways from…
25 Sept 2026
TARC Q3 FY24: Revenue ₹930.10 Cr, PAT ₹3,349.00 Cr | Arthneeti
Q3 FY24
Q3 FY24 Revenue: ₹930.10 crore (from page 18) . Key concall takeaways from TARC Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.
25 Sept 2026
TARC Q4 FY23 earnings call: Revenue & Margins | Arthneeti
Q4 FY23
Q4 FY23 Total Income:** INR 135.5 crores . Key concall takeaways from TARC Ltd's Q4 FY23 earnings call — and how it ranks against sector peers.
25 Sept 2026
RattanIndia Power Q3 FY25 earnings call: Revenue & Margins | Arthneeti
Q3 FY25
806.38 crore, up from Rs. Key concall takeaways from RattanIndia Power Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
25 Sept 2026
RattanIndia Power Q4 FY26 earnings call: Revenue & Margins | Arthneeti
Q4 FY26
798.55 Cr, down from Rs. Key concall takeaways from RattanIndia Power Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
25 Sept 2026